Literature DB >> 18685014

Differentiation of highly virulent strains of Streptococcus suis serotype 2 according to glutamate dehydrogenase electrophoretic and sequence type.

Russell Kutz1, Ogi Okwumabua.   

Abstract

The glutamate dehydrogenase (GDH) enzymes of 19 Streptococcus suis serotype 2 strains, consisting of 18 swine isolates and 1 human clinical isolate from a geographically varied collection, were analyzed by activity staining on a nondenaturing gel. All seven (100%) of the highly virulent strains tested produced an electrophoretic type (ET) distinct from those of moderately virulent and nonvirulent strains. By PCR and nucleotide sequence determination, the gdh genes of the 19 strains and of 2 highly virulent strains involved in recent Chinese outbreaks yielded a 1,820-bp fragment containing an open reading frame of 1,344 nucleotides, which encodes a protein of 448 amino acid residues with a calculated molecular mass of approximately 49 kDa. The nucleotide sequences contained base pair differences, but most were silent. Cluster analysis of the deduced amino acid sequences separated the isolates into three groups. Group I (ETI) consisted of the seven highly virulent isolates and the two Chinese outbreak strains, containing Ala(299)-to-Ser, Glu(305)-to-Lys, and Glu(330)-to-Lys amino acid substitutions compared with groups II and III (ETII). Groups II and III consisted of moderately virulent and nonvirulent strains, which are separated from each other by Tyr(72)-to-Asp and Thr(296)-to-Ala substitutions. Gene exchange studies resulted in the change of ETI to ETII and vice versa. A spectrophotometric activity assay for GDH did not show significant differences between the groups. These results suggest that the GDH ETs and sequence types may serve as useful markers in predicting the pathogenic behavior of strains of this serotype and that the molecular basis for the observed differences in the ETs was amino acid substitutions and not deletion, insertion, or processing uniqueness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685014      PMCID: PMC2566107          DOI: 10.1128/JCM.02309-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

Review 1.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

2.  Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs.

Authors:  H E Smith; U Vecht; H J Wisselink; N Stockhofe-Zurwieden; Y Biermann; M A Smits
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes.

Authors:  J L Gaillard; P Berche; P Sansonetti
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

4.  Streptococcus suis serotype 2 mutants deficient in capsular expression.

Authors:  N Charland; J Harel; M Kobisch; S Lacasse; M Gottschalk
Journal:  Microbiology (Reading)       Date:  1998-02       Impact factor: 2.777

5.  Use of ribotyping and hemolysin activity to identify highly virulent Streptococcus suis type 2 isolates.

Authors:  J J Staats; B L Plattner; J Nietfeld; S Dritz; M M Chengappa
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 6.  Streptococcus suis: past and present.

Authors:  J J Staats; I Feder; O Okwumabua; M M Chengappa
Journal:  Vet Res Commun       Date:  1997-08       Impact factor: 2.459

7.  Detection of genomic heterogeneity in Streptococcus suis isolates by DNA restriction fragment length polymorphisms of rRNA genes (ribotyping).

Authors:  O Okwumabua; J Staats; M M Chengappa
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

8.  Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis.

Authors:  A A Jacobs; P L Loeffen; A J van den Berg; P K Storm
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins.

Authors:  S Quessy; J D Dubreuil; M Caya; R Higgins
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Identification of two proteins associated with virulence of Streptococcus suis type 2.

Authors:  U Vecht; H J Wisselink; M L Jellema; H E Smith
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more
  3 in total

1.  Genetic and virulence characterization of Streptococcus suis type 2 isolates from swine in the provinces of Zhejiang and Henan, China.

Authors:  Yulong Tang; Huancan Zhao; Wei Wu; Di Wu; Xiaoliang Li; Weihuan Fang
Journal:  Folia Microbiol (Praha)       Date:  2011-11-15       Impact factor: 2.099

2.  The identification of six novel proteins with fibronectin or collagen type I binding activity from Streptococcus suis serotype 2.

Authors:  Hui Zhang; Junxi Zheng; Li Yi; Yue Li; Zhe Ma; Hongjie Fan; Chengping Lu
Journal:  J Microbiol       Date:  2014-10-31       Impact factor: 3.422

3.  Antimicrobial Resistance Profile and Genotypic Characteristics of Streptococcus suis Capsular Type 2 Isolated from Clinical Carrier Sows and Diseased Pigs in China.

Authors:  Chunping Zhang; Zhongqiu Zhang; Li Song; Xuezheng Fan; Fang Wen; Shixin Xu; Yibao Ning
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.